# Rescue Therapy for Helicobacter Pylori Eradication Treatment

> **NCT04531059** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 368 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Bismuth Potassium Citrate
- **DRUG:** Tetracycline,Metronidazole
- **DRUG:** Minocycline,Metronidazole

## Key facts

- **NCT ID:** NCT04531059
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-31
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531059, "Rescue Therapy for Helicobacter Pylori Eradication Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04531059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*